当前位置: X-MOL 学术Mol. Immunol. › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Toll-like receptor 4 knockout protects against diabetic-induced imbalance of bone metabolism via autophagic suppression.
Molecular Immunology ( IF 3.6 ) Pub Date : 2019-11-12 , DOI: 10.1016/j.molimm.2019.10.025
Yongze Zhang 1 , Ximei Shen 1 , Ling Cheng 1 , Ran Chen 1 , Fengying Zhao 1 , Shuai Zhong 1 , Chao Lan 1 , Sunjie Yan 1
Affiliation  

OBJECTIVE This study aimed to elucidate the mechanism of autophagy in bone metabolism in high-glucose environments and its relationship with Toll-like receptor 4 (TLR4). METHODS A TLR4 knockout diabetic rat model and MC3T3-E1 with TLR4 silencing by small interfering RNA were used to observe the protective mechanism of TLR4 knockdown or silencing in hyperglycemia-induced bone injury. RESULTS The inhibition of TLR4 expression improved bone metabolism and bone structure; promoted alkaline phosphatase (ALP) and osteocalcin (OCN) secretion, enhanced bone morphogenic protein (BMP)-2 expression, promoted bone mineralization, and reduced hyperglycemia-induced osteoblast apoptosis. TLR4 knockdown or silencing reduced the levels of inflammatory factors interleukin (IL)-1, IL-6, and tumor necrosis factor-alpha at the animal and cell levels, inhibited the expression of inflammatory pathway proteins, and downregulated the expression of Beclin 1 and LC3II/LC-1 proteins. The inhibition of autophagic activity enhanced the osteoprotective effect of TLR4 knockdown, improved cell viability, reduced the apoptosis rate of osteoblasts, and promoted the BMP-2 protein level and ALP and OCN secretion. Conversely, the activation of autophagy significantly aggravated osteoblast apoptosis, reduced BMP-2 protein levels, and inhibited ALP and OCN secretion. CONCLUSION Taken together, the experimental results supported the hypothesis that TLR4 deficiency might alleviate hyperglycemia-induced apoptosis and differentiation suppression in osteoblasts and exert osteoprotective effects via autophagic inhibition.

中文翻译:

Toll样受体4敲除可通过自噬抑制作用来预防糖尿病引起的骨代谢失衡。

目的本研究旨在阐明高糖环境下骨代谢中自噬的机制及其与Toll样受体4(TLR4)的关系。方法采用TLR4基因敲除糖尿病大鼠模型,并通过小干扰RNA沉默TLR4基因沉默MC3T3-E1,观察TLR4基因敲低或沉默对高血糖引起的骨损伤的保护机制。结果抑制TLR4表达可改善骨代谢和骨骼结构。促进碱性磷酸酶(ALP)和骨钙蛋白(OCN)的分泌,增强骨形态发生蛋白(BMP)-2的表达,促进骨矿化,并减少高血糖症诱导的成骨细胞凋亡。在动物和细胞水平上,TLR4抑制或沉默可降低炎症因子白介素(IL)-1,IL-6和肿瘤坏死因子-α的水平,抑制炎症途径蛋白的表达,并下调Beclin 1和LC3II / LC-1蛋白的表达。自噬活性的抑制增强了TLR4敲低的骨保护作用,改善了细胞活力,降低了成骨细胞的凋亡率,并促进了BMP-2蛋白水平以及ALP和OCN的分泌。相反,自噬的激活显着加重了成骨细胞凋亡,降低了BMP-2蛋白水平,并抑制了ALP和OCN的分泌。结论综上所述,实验结果支持以下假设:TLR4缺乏可能减轻高血糖诱导的成骨细胞凋亡和分化抑制,并通过自噬抑制发挥骨保护作用。并下调Beclin 1和LC3II / LC-1蛋白的表达。自噬活性的抑制增强了TLR4敲低的骨保护作用,改善了细胞活力,降低了成骨细胞的凋亡率,并促进了BMP-2蛋白水平以及ALP和OCN的分泌。相反,自噬的激活显着加重了成骨细胞凋亡,降低了BMP-2蛋白水平,并抑制了ALP和OCN的分泌。结论综上所述,实验结果支持以下假设:TLR4缺乏可能减轻高血糖诱导的成骨细胞凋亡和分化抑制,并通过自噬抑制发挥骨保护作用。并下调Beclin 1和LC3II / LC-1蛋白的表达。自噬活性的抑制增强了TLR4敲低的骨保护作用,改善了细胞活力,降低了成骨细胞的凋亡率,并促进了BMP-2蛋白水平以及ALP和OCN的分泌。相反,自噬的激活显着加重了成骨细胞凋亡,降低了BMP-2蛋白水平,并抑制了ALP和OCN的分泌。结论综上所述,实验结果支持以下假设:TLR4缺乏可能减轻高血糖诱导的成骨细胞凋亡和分化抑制,并通过自噬抑制发挥骨保护作用。降低成骨细胞的凋亡率,并促进BMP-2蛋白水平以及ALP和OCN的分泌。相反,自噬的激活显着加重了成骨细胞凋亡,降低了BMP-2蛋白水平,并抑制了ALP和OCN的分泌。结论综上所述,实验结果支持以下假设:TLR4缺乏可能减轻高血糖诱导的成骨细胞凋亡和分化抑制,并通过自噬抑制发挥骨保护作用。降低成骨细胞的凋亡率,并促进BMP-2蛋白水平以及ALP和OCN分泌。相反,自噬的激活显着加重了成骨细胞凋亡,降低了BMP-2蛋白水平,并抑制了ALP和OCN的分泌。结论综上所述,实验结果支持以下假设:TLR4缺乏可能减轻高血糖诱导的成骨细胞凋亡和分化抑制,并通过自噬抑制发挥骨保护作用。
更新日期:2019-11-12
down
wechat
bug